دورية أكاديمية

Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene.

التفاصيل البيبلوغرافية
العنوان: Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene.
المؤلفون: Panova AV; Endocrinology Research Centre, Moscow, Russia; Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia. Electronic address: a.v.panova@mail.ru., Kulikova KS; Endocrinology Research Centre, Moscow, Russia., Klementieva NV; Endocrinology Research Centre, Moscow, Russia., Krylov ID; Endocrinology Research Centre, Moscow, Russia., Snezhko IO; Endocrinology Research Centre, Moscow, Russia., Tiulpakov AN; Endocrinology Research Centre, Moscow, Russia; Research Centre for Medical Genetics, Moscow, Russia., Kiselev SL; Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.
المصدر: Stem cell research [Stem Cell Res] 2021 Jul; Vol. 54, pp. 102414. Date of Electronic Publication: 2021 Jun 04.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101316957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7753 (Electronic) Linking ISSN: 18735061 NLM ISO Abbreviation: Stem Cell Res Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Kidlington, Oxford : Elsevier
مواضيع طبية MeSH: Hypercalcemia* , Hyperparathyroidism, Primary*/genetics , Induced Pluripotent Stem Cells*, Humans ; Infant, Newborn ; Mutation ; Receptors, Calcium-Sensing/genetics
مستخلص: Neonatal severe primary hyperparathyroidism (NSHPT) is a rare autosomal recessive disorder of calcium homeostasis that manifests shortly after birth with hypercalcemia and bone disease. NSHPT, in most cases, is attributed to mutations in the calcium-sensing receptor (CASR) gene. We reprogrammed dermal fibroblasts derived from a patient with NSHPT carrying a compound heterozygous mutation in the CASR gene into induced pluripotent stem cells (iPSCs). The established iPSCs expressed pluripotency markers, maintained normal karyotype and differentiated into all three germ layers. This line is a valuable resource for modeling of hyperparathyroidism related to CASR mutations.
(Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.)
المشرفين على المادة: 0 (CASR protein, human)
0 (Receptors, Calcium-Sensing)
تواريخ الأحداث: Date Created: 20210610 Date Completed: 20210805 Latest Revision: 20210805
رمز التحديث: 20240628
DOI: 10.1016/j.scr.2021.102414
PMID: 34111698
قاعدة البيانات: MEDLINE
الوصف
تدمد:1876-7753
DOI:10.1016/j.scr.2021.102414